Upgrade to SI Premium - Free Trial

UBS Reiterates Buy Rating on Abbott Labs (ABT) on EPD Strength

October 19, 2026 9:33 AM
UBS analyst Patrick Wood reiterated a Buy rating and $125.00 price target on Abbott Labs (NYSE: ABT).The analyst commented, "EPD ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments